Promising drug targets and associated therapeutic interventions in Parkinson’s disease

Parkinson’s disease (PD) is one of the most debilitating brain diseases. Despite the availability of symptomatic treatments, response towards the health of PD patients remains scarce. To fulfil the medical needs of the PD patients, an efficacious and etiological treatment is required. In this review...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Sachchida Nand, Singh, Payal, Varshney, Ritu, Chaturvedi, Vivek K., Vamanu, Emanuel, Singh, M. P., Singh, Brijesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328771/
https://www.ncbi.nlm.nih.gov/pubmed/33510062
http://dx.doi.org/10.4103/1673-5374.306066
Descripción
Sumario:Parkinson’s disease (PD) is one of the most debilitating brain diseases. Despite the availability of symptomatic treatments, response towards the health of PD patients remains scarce. To fulfil the medical needs of the PD patients, an efficacious and etiological treatment is required. In this review, we have compiled the information covering limitations of current therapeutic options in PD, novel drug targets for PD, and finally, the role of some critical beneficial natural products to control the progression of PD.

Ejemplares similares